1 Study Coverage
    1.1 Nasal Decongestant Product Introduction
    1.2 Market by Type
        1.2.1 Global Nasal Decongestant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Nasal Strips
        1.2.3 Tablet
        1.2.4 Spray
        1.2.5 Capsule
    1.3 Market by Application
        1.3.1 Global Nasal Decongestant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Asthma
        1.3.3 Cold
        1.3.4 Nasal Allergies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Nasal Decongestant Sales Estimates and Forecasts 2017-2028
    2.2 Global Nasal Decongestant Revenue Estimates and Forecasts 2017-2028
    2.3 Global Nasal Decongestant Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Nasal Decongestant Sales by Region
        2.4.1 Global Nasal Decongestant Sales by Region (2017-2022)
        2.4.2 Global Sales Nasal Decongestant by Region (2023-2028)
    2.5 Global Nasal Decongestant Revenue by Region
        2.5.1 Global Nasal Decongestant Revenue by Region (2017-2022)
        2.5.2 Global Nasal Decongestant Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Nasal Decongestant Sales by Manufacturers
        3.1.1 Global Top Nasal Decongestant Manufacturers by Sales (2017-2022)
        3.1.2 Global Nasal Decongestant Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nasal Decongestant in 2021
    3.2 Global Nasal Decongestant Revenue by Manufacturers
        3.2.1 Global Nasal Decongestant Revenue by Manufacturers (2017-2022)
        3.2.2 Global Nasal Decongestant Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Nasal Decongestant Revenue in 2021
    3.3 Global Nasal Decongestant Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Nasal Decongestant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Nasal Decongestant Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Nasal Decongestant Sales by Type
        4.1.1 Global Nasal Decongestant Historical Sales by Type (2017-2022)
        4.1.2 Global Nasal Decongestant Forecasted Sales by Type (2023-2028)
        4.1.3 Global Nasal Decongestant Sales Market Share by Type (2017-2028)
    4.2 Global Nasal Decongestant Revenue by Type
        4.2.1 Global Nasal Decongestant Historical Revenue by Type (2017-2022)
        4.2.2 Global Nasal Decongestant Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Nasal Decongestant Revenue Market Share by Type (2017-2028)
    4.3 Global Nasal Decongestant Price by Type
        4.3.1 Global Nasal Decongestant Price by Type (2017-2022)
        4.3.2 Global Nasal Decongestant Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Nasal Decongestant Sales by Application
        5.1.1 Global Nasal Decongestant Historical Sales by Application (2017-2022)
        5.1.2 Global Nasal Decongestant Forecasted Sales by Application (2023-2028)
        5.1.3 Global Nasal Decongestant Sales Market Share by Application (2017-2028)
    5.2 Global Nasal Decongestant Revenue by Application
        5.2.1 Global Nasal Decongestant Historical Revenue by Application (2017-2022)
        5.2.2 Global Nasal Decongestant Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Nasal Decongestant Revenue Market Share by Application (2017-2028)
    5.3 Global Nasal Decongestant Price by Application
        5.3.1 Global Nasal Decongestant Price by Application (2017-2022)
        5.3.2 Global Nasal Decongestant Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Nasal Decongestant Market Size by Type
        6.1.1 North America Nasal Decongestant Sales by Type (2017-2028)
        6.1.2 North America Nasal Decongestant Revenue by Type (2017-2028)
    6.2 North America Nasal Decongestant Market Size by Application
        6.2.1 North America Nasal Decongestant Sales by Application (2017-2028)
        6.2.2 North America Nasal Decongestant Revenue by Application (2017-2028)
    6.3 North America Nasal Decongestant Market Size by Country
        6.3.1 North America Nasal Decongestant Sales by Country (2017-2028)
        6.3.2 North America Nasal Decongestant Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Nasal Decongestant Market Size by Type
        7.1.1 Europe Nasal Decongestant Sales by Type (2017-2028)
        7.1.2 Europe Nasal Decongestant Revenue by Type (2017-2028)
    7.2 Europe Nasal Decongestant Market Size by Application
        7.2.1 Europe Nasal Decongestant Sales by Application (2017-2028)
        7.2.2 Europe Nasal Decongestant Revenue by Application (2017-2028)
    7.3 Europe Nasal Decongestant Market Size by Country
        7.3.1 Europe Nasal Decongestant Sales by Country (2017-2028)
        7.3.2 Europe Nasal Decongestant Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Nasal Decongestant Market Size by Type
        8.1.1 Asia Pacific Nasal Decongestant Sales by Type (2017-2028)
        8.1.2 Asia Pacific Nasal Decongestant Revenue by Type (2017-2028)
    8.2 Asia Pacific Nasal Decongestant Market Size by Application
        8.2.1 Asia Pacific Nasal Decongestant Sales by Application (2017-2028)
        8.2.2 Asia Pacific Nasal Decongestant Revenue by Application (2017-2028)
    8.3 Asia Pacific Nasal Decongestant Market Size by Region
        8.3.1 Asia Pacific Nasal Decongestant Sales by Region (2017-2028)
        8.3.2 Asia Pacific Nasal Decongestant Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Nasal Decongestant Market Size by Type
        9.1.1 Latin America Nasal Decongestant Sales by Type (2017-2028)
        9.1.2 Latin America Nasal Decongestant Revenue by Type (2017-2028)
    9.2 Latin America Nasal Decongestant Market Size by Application
        9.2.1 Latin America Nasal Decongestant Sales by Application (2017-2028)
        9.2.2 Latin America Nasal Decongestant Revenue by Application (2017-2028)
    9.3 Latin America Nasal Decongestant Market Size by Country
        9.3.1 Latin America Nasal Decongestant Sales by Country (2017-2028)
        9.3.2 Latin America Nasal Decongestant Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Nasal Decongestant Market Size by Type
        10.1.1 Middle East and Africa Nasal Decongestant Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Nasal Decongestant Revenue by Type (2017-2028)
    10.2 Middle East and Africa Nasal Decongestant Market Size by Application
        10.2.1 Middle East and Africa Nasal Decongestant Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Nasal Decongestant Revenue by Application (2017-2028)
    10.3 Middle East and Africa Nasal Decongestant Market Size by Country
        10.3.1 Middle East and Africa Nasal Decongestant Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Nasal Decongestant Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Corporation Information
        11.1.2 Abbott Laboratories Overview
        11.1.3 Abbott Laboratories Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Laboratories Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Glaxosmithkline
        11.2.1 Glaxosmithkline Corporation Information
        11.2.2 Glaxosmithkline Overview
        11.2.3 Glaxosmithkline Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Glaxosmithkline Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Glaxosmithkline Recent Developments
    11.3 Cipla
        11.3.1 Cipla Corporation Information
        11.3.2 Cipla Overview
        11.3.3 Cipla Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Cipla Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Cipla Recent Developments
    11.4 Bayer
        11.4.1 Bayer Corporation Information
        11.4.2 Bayer Overview
        11.4.3 Bayer Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bayer Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bayer Recent Developments
    11.5 ADAPT Pharma
        11.5.1 ADAPT Pharma Corporation Information
        11.5.2 ADAPT Pharma Overview
        11.5.3 ADAPT Pharma Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 ADAPT Pharma Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 ADAPT Pharma Recent Developments
    11.6 Patrick Parsons
        11.6.1 Patrick Parsons Corporation Information
        11.6.2 Patrick Parsons Overview
        11.6.3 Patrick Parsons Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Patrick Parsons Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Patrick Parsons Recent Developments
    11.7 Nidda Healthcare
        11.7.1 Nidda Healthcare Corporation Information
        11.7.2 Nidda Healthcare Overview
        11.7.3 Nidda Healthcare Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Nidda Healthcare Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Nidda Healthcare Recent Developments
    11.8 Procter and Gamble
        11.8.1 Procter and Gamble Corporation Information
        11.8.2 Procter and Gamble Overview
        11.8.3 Procter and Gamble Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Procter and Gamble Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Procter and Gamble Recent Developments
    11.9 Rugby Laboratories
        11.9.1 Rugby Laboratories Corporation Information
        11.9.2 Rugby Laboratories Overview
        11.9.3 Rugby Laboratories Nasal Decongestant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Rugby Laboratories Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Rugby Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Nasal Decongestant Industry Chain Analysis
    12.2 Nasal Decongestant Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Nasal Decongestant Production Mode & Process
    12.4 Nasal Decongestant Sales and Marketing
        12.4.1 Nasal Decongestant Sales Channels
        12.4.2 Nasal Decongestant Distributors
    12.5 Nasal Decongestant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Nasal Decongestant Industry Trends
    13.2 Nasal Decongestant Market Drivers
    13.3 Nasal Decongestant Market Challenges
    13.4 Nasal Decongestant Market Restraints
14 Key Findings in The Global Nasal Decongestant Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Nasal Decongestant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Nasal Strips
    Table 3. Major Manufacturers of Tablet
    Table 4. Major Manufacturers of Spray
    Table 5. Major Manufacturers of Capsule
    Table 6. Global Nasal Decongestant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Nasal Decongestant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Nasal Decongestant Sales by Region (2017-2022) & (K Units)
    Table 9. Global Nasal Decongestant Sales Market Share by Region (2017-2022)
    Table 10. Global Nasal Decongestant Sales by Region (2023-2028) & (K Units)
    Table 11. Global Nasal Decongestant Sales Market Share by Region (2023-2028)
    Table 12. Global Nasal Decongestant Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Nasal Decongestant Revenue Market Share by Region (2017-2022)
    Table 14. Global Nasal Decongestant Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Nasal Decongestant Revenue Market Share by Region (2023-2028)
    Table 16. Global Nasal Decongestant Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Nasal Decongestant Sales Share by Manufacturers (2017-2022)
    Table 18. Global Nasal Decongestant Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Nasal Decongestant Revenue Share by Manufacturers (2017-2022)
    Table 20. Nasal Decongestant Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 21. Global Nasal Decongestant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Nasal Decongestant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Decongestant as of 2021)
    Table 23. Nasal Decongestant Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Nasal Decongestant Product Offered
    Table 25. Date of Manufacturers Enter into Nasal Decongestant Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Nasal Decongestant Sales by Type (2017-2022) & (K Units)
    Table 28. Global Nasal Decongestant Sales by Type (2023-2028) & (K Units)
    Table 29. Global Nasal Decongestant Sales Share by Type (2017-2022)
    Table 30. Global Nasal Decongestant Sales Share by Type (2023-2028)
    Table 31. Global Nasal Decongestant Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Nasal Decongestant Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Nasal Decongestant Revenue Share by Type (2017-2022)
    Table 34. Global Nasal Decongestant Revenue Share by Type (2023-2028)
    Table 35. Nasal Decongestant Price by Type (2017-2022) & (US$/Unit)
    Table 36. Global Nasal Decongestant Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 37. Global Nasal Decongestant Sales by Application (2017-2022) & (K Units)
    Table 38. Global Nasal Decongestant Sales by Application (2023-2028) & (K Units)
    Table 39. Global Nasal Decongestant Sales Share by Application (2017-2022)
    Table 40. Global Nasal Decongestant Sales Share by Application (2023-2028)
    Table 41. Global Nasal Decongestant Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Nasal Decongestant Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Nasal Decongestant Revenue Share by Application (2017-2022)
    Table 44. Global Nasal Decongestant Revenue Share by Application (2023-2028)
    Table 45. Nasal Decongestant Price by Application (2017-2022) & (US$/Unit)
    Table 46. Global Nasal Decongestant Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 47. North America Nasal Decongestant Sales by Type (2017-2022) & (K Units)
    Table 48. North America Nasal Decongestant Sales by Type (2023-2028) & (K Units)
    Table 49. North America Nasal Decongestant Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Nasal Decongestant Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Nasal Decongestant Sales by Application (2017-2022) & (K Units)
    Table 52. North America Nasal Decongestant Sales by Application (2023-2028) & (K Units)
    Table 53. North America Nasal Decongestant Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Nasal Decongestant Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Nasal Decongestant Sales by Country (2017-2022) & (K Units)
    Table 56. North America Nasal Decongestant Sales by Country (2023-2028) & (K Units)
    Table 57. North America Nasal Decongestant Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Nasal Decongestant Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Nasal Decongestant Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Nasal Decongestant Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Nasal Decongestant Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Nasal Decongestant Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Nasal Decongestant Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Nasal Decongestant Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Nasal Decongestant Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Nasal Decongestant Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Nasal Decongestant Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Nasal Decongestant Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Nasal Decongestant Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Nasal Decongestant Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Nasal Decongestant Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Nasal Decongestant Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Nasal Decongestant Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Nasal Decongestant Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Nasal Decongestant Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Nasal Decongestant Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Nasal Decongestant Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Nasal Decongestant Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Nasal Decongestant Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Nasal Decongestant Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Nasal Decongestant Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Nasal Decongestant Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Nasal Decongestant Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Nasal Decongestant Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Nasal Decongestant Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Nasal Decongestant Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Nasal Decongestant Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Nasal Decongestant Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Nasal Decongestant Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Nasal Decongestant Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Nasal Decongestant Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Nasal Decongestant Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Nasal Decongestant Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Nasal Decongestant Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Nasal Decongestant Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Nasal Decongestant Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Nasal Decongestant Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Nasal Decongestant Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Nasal Decongestant Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Nasal Decongestant Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Nasal Decongestant Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Nasal Decongestant Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Nasal Decongestant Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Nasal Decongestant Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Nasal Decongestant Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Nasal Decongestant Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Abbott Laboratories Corporation Information
    Table 108. Abbott Laboratories Description and Major Businesses
    Table 109. Abbott Laboratories Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Abbott Laboratories Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Abbott Laboratories Recent Developments
    Table 112. Glaxosmithkline Corporation Information
    Table 113. Glaxosmithkline Description and Major Businesses
    Table 114. Glaxosmithkline Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Glaxosmithkline Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Glaxosmithkline Recent Developments
    Table 117. Cipla Corporation Information
    Table 118. Cipla Description and Major Businesses
    Table 119. Cipla Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. Cipla Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Cipla Recent Developments
    Table 122. Bayer Corporation Information
    Table 123. Bayer Description and Major Businesses
    Table 124. Bayer Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. Bayer Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Bayer Recent Developments
    Table 127. ADAPT Pharma Corporation Information
    Table 128. ADAPT Pharma Description and Major Businesses
    Table 129. ADAPT Pharma Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. ADAPT Pharma Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. ADAPT Pharma Recent Developments
    Table 132. Patrick Parsons Corporation Information
    Table 133. Patrick Parsons Description and Major Businesses
    Table 134. Patrick Parsons Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 135. Patrick Parsons Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Patrick Parsons Recent Developments
    Table 137. Nidda Healthcare Corporation Information
    Table 138. Nidda Healthcare Description and Major Businesses
    Table 139. Nidda Healthcare Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 140. Nidda Healthcare Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Nidda Healthcare Recent Developments
    Table 142. Procter and Gamble Corporation Information
    Table 143. Procter and Gamble Description and Major Businesses
    Table 144. Procter and Gamble Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 145. Procter and Gamble Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Procter and Gamble Recent Developments
    Table 147. Rugby Laboratories Corporation Information
    Table 148. Rugby Laboratories Description and Major Businesses
    Table 149. Rugby Laboratories Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 150. Rugby Laboratories Nasal Decongestant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Rugby Laboratories Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Nasal Decongestant Distributors List
    Table 155. Nasal Decongestant Customers List
    Table 156. Nasal Decongestant Market Trends
    Table 157. Nasal Decongestant Market Drivers
    Table 158. Nasal Decongestant Market Challenges
    Table 159. Nasal Decongestant Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nasal Decongestant Product Picture
    Figure 3. Global Nasal Decongestant Market Share by Type in 2021 & 2028
    Figure 3. Nasal Strips Product Picture
    Figure 4. Tablet Product Picture
    Figure 5. Spray Product Picture
    Figure 6. Capsule Product Picture
    Figure 7. Global Nasal Decongestant Market Share by Application in 2021 & 2028
    Figure 8. Asthma
    Figure 9. Cold
    Figure 10. Nasal Allergies
    Figure 11. Nasal Decongestant Report Years Considered
    Figure 12. Global Nasal Decongestant Sales 2017-2028 (K Units)
    Figure 13. Global Nasal Decongestant Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Nasal Decongestant Revenue 2017-2028 (US$ Million)
    Figure 15. Global Nasal Decongestant Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Nasal Decongestant Sales Market Share by Region (2017-2022)
    Figure 17. Global Nasal Decongestant Sales Market Share by Region (2023-2028)
    Figure 18. North America Nasal Decongestant Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Nasal Decongestant Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Nasal Decongestant Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Nasal Decongestant Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Nasal Decongestant Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Nasal Decongestant Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Nasal Decongestant Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Nasal Decongestant Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Nasal Decongestant Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Nasal Decongestant Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Nasal Decongestant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Nasal Decongestant in the World: Market Share by Nasal Decongestant Revenue in 2021
    Figure 30. Global Nasal Decongestant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Nasal Decongestant Sales Market Share by Type (2017-2028)
    Figure 32. Global Nasal Decongestant Revenue Market Share by Type (2017-2028)
    Figure 33. Global Nasal Decongestant Sales Market Share by Application (2017-2028)
    Figure 34. Global Nasal Decongestant Revenue Market Share by Application (2017-2028)
    Figure 35. North America Nasal Decongestant Sales Market Share by Type (2017-2028)
    Figure 36. North America Nasal Decongestant Revenue Market Share by Type (2017-2028)
    Figure 37. North America Nasal Decongestant Sales Market Share by Application (2017-2028)
    Figure 38. North America Nasal Decongestant Revenue Market Share by Application (2017-2028)
    Figure 39. North America Nasal Decongestant Sales Share by Country (2017-2028)
    Figure 40. North America Nasal Decongestant Revenue Share by Country (2017-2028)
    Figure 41. United States Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Nasal Decongestant Sales Market Share by Type (2017-2028)
    Figure 44. Europe Nasal Decongestant Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Nasal Decongestant Sales Market Share by Application (2017-2028)
    Figure 46. Europe Nasal Decongestant Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Nasal Decongestant Sales Share by Country (2017-2028)
    Figure 48. Europe Nasal Decongestant Revenue Share by Country (2017-2028)
    Figure 49. Germany Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 50. France Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Nasal Decongestant Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Nasal Decongestant Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Nasal Decongestant Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Nasal Decongestant Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Nasal Decongestant Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Nasal Decongestant Revenue Share by Region (2017-2028)
    Figure 60. China Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 63. India Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Nasal Decongestant Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Nasal Decongestant Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Nasal Decongestant Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Nasal Decongestant Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Nasal Decongestant Sales Share by Country (2017-2028)
    Figure 74. Latin America Nasal Decongestant Revenue Share by Country (2017-2028)
    Figure 75. Mexico Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Nasal Decongestant Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Nasal Decongestant Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Nasal Decongestant Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Nasal Decongestant Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Nasal Decongestant Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Nasal Decongestant Revenue Share by Country (2017-2028)
    Figure 84. Turkey Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Nasal Decongestant Revenue (2017-2028) & (US$ Million)
    Figure 87. Nasal Decongestant Value Chain
    Figure 88. Nasal Decongestant Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed